A potent nonporphyrin class of photodynamic therapeutic agent: Cellular localisation, cytotoxic potential and influence of hypoxia

British Journal of Cancer

Volumn 92, Issue 9, 2005, Pages 1702-1710

  Gallagher, W M ^a   Allen, L T ^a   O'Shea, C ^a   Kenna, T ^a   Hall, M ^a   Gorman, A ^a   Killoran, J ^a   O'Shea, D F ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cellular localisation; Cytotoxic potential; Photodynamic therapeutic agent

Indexed keywords

ADPM 01; ADPM 06; AZADIPYRROMETHENE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE MICROSCOPY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL;

APOPTOSIS; CELL HYPOXIA; CELL LINE, TUMOR; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; HUMANS; LIGHT; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PYRROLES;

EID: 19944364152     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602527     Document Type: Article

References (26)

1. Dellinger M (1996) Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol. Photochem Photobiol 64: 182-187
2. Dolmans DE, Fukumura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3: 380-387
3. Foster TH, Murant RS, Bryant RG, Knox RS, Gibson SL, Hilf R (1991) Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 126: 296-303
4. Gelderblom H, Verweij J, Nooter K, Sparreboom A (2001) Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer 37: 1590-1598
5. German A, Killoran J, O'Shea C, Kenna T, Gallagher WM, O'Shea DF (2004) In vitro demonstration of the heavy-atom effect for photodynamic therapy. J Am Chem Soc 126: 10619-10631
6. Grebeòová D, Kuželová K, Smetana K, Pluskalová M, Cajthamlová H, Marinov I, Fuchs O, Souèek J, Jarolím P, Hrkal Z (2003) Mitochondrial and endoplasmic reticulum stress induced apoptotic pathways are activated by 5-aminolevulinic acid based photodynamic therapy in HL60 leukemia cells. J Photochem Photobiol B 69: 71-85
7. Gupta S, Dwarakanath BS, Muralidhar K, Jain V (2003) Cellular uptake, localisation and photodynamic effects of haematoporphyrin derivative in human glioma and squamous carcinoma cell lines. J Photochem Photobiol B 69: 107-120
8. Henderson BW, Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55: 145-157
9. Kessel D, Luo Y (1998) Mitochondrial photodamage and PDT-induced apoptosis. J Photochem Photobiol B 42: 89-95
10. Khanum F, Jain V (1997) Cellular accumulation and biological activity of hematoporphyrin derivative(L) in comparison with photofrin II. Indian J Exp Biol 35: 348-355
11. MacDonald IJ, Dougherty TJJ (2001) Basic principals of photodynamic therapy. Porphyrins Phthalocyanines 5: 105-129
12. Mitchell JB, McPherson S, DeGraff W, Gamson J, Zabell A, Russo A (1985) Oxygen dependence of hematoporphyrin derivative-induced photoinactivation of Chinese hamster cells. Cancer Res 45: 2008-2011
13. Moan J, Berg K (1991) The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem Photobiol 53: 549-553
14. Moan J, Sommer S (1985) Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res 45: 1608-1610
15. Morgan J, Oseroff AR (2001) Mitochondria-based photodynamic anti-cancer therapy. Adv Drug Deliv Rev 49: 71-86
16. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM (1996) Apoptosis and necrosis induced with light and 5-aminolevulinic acid-derived protoporphyrin IX. Br J Cancer 74: 22-29
17. Noodt BB, Berg K, Stokke T, Peng Q, Nesland JM (1999) Different apoptotic pathways are induced from various intracellular sites by tetraphenylporphyrins and light. Br J Cancer 79: 72-81
18. Oleinick NL, Morris RL, Belichenko I (2002) The role of apoptosis in response to photodynamic therapy: what, where, why and how. Photochem Photobiol Sci 1: 1-21
19. Peng Q, Moan J, Nesland JM (1996) Correlation of subcellular and intratumoral photosensitizer localisation with ultrastructural features after photodynamic therapy. Ultrastruct Pathol 20: 109-129
20. Reed MW, Mullins AP, Anderson GL, Miller FN, Wieman TJ (1989) The effect of photodynamic therapy on tumour oxygenation. Surgery 106: 94-99
21. Sharman WM, Allen CM, van Lier JE (1999) Photodynamic therapeutics: basic principles and clinical applications. Drug Discov Today 4: 507-517
22. Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ (2001) Photodynamic therapy in oncology. Expert Opin Pharmacother 2: 917-927
23. Teilen M-H, Bezdetnaya L, Morliere P, Santus R, Guillemin F (2003) Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultered tumour cells. Br J Cancer 88: 146-152
24. Wainwright M (1996) Non-porphyrin photosensitizers in biomedicine. Chem Soc Rev 25: 351-359
25. Weishaupt KR, Corner CJ, Dougherty TJ (1976) Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumour. Cancer Res 36: 2326-2329
26. Wyld L, Reed MWR, Brown NJ (1998) The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro. Br J Cancer 77: 1621-1627